Entity Common Stock, Shares Outstanding of Apellis Pharmaceuticals, Inc. from 20 Dec 2017 to 23 Oct 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Apellis Pharmaceuticals, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 20 Dec 2017 to 23 Oct 2025.
  • Apellis Pharmaceuticals, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 23 Oct 2025 was 126,525,218, a 1.7% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Apellis Pharmaceuticals, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 126,525,218 +2,132,201 +1.7% 23 Oct 2025 10-Q 30 Oct 2025 2025 Q3
Q2 2025 126,289,910 +4,523,582 +3.7% 24 Jul 2025 10-Q 31 Jul 2025 2025 Q2
Q1 2025 125,682,260 +4,316,705 +3.6% 30 Apr 2025 10-Q 07 May 2025 2025 Q1
Q3 2024 124,393,017 +5,893,072 +5% 29 Oct 2024 10-Q 05 Nov 2024 2024 Q3
Q2 2024 121,766,328 +4,029,039 +3.4% 25 Jul 2024 10-Q 01 Aug 2024 2024 Q2
Q1 2024 121,365,555 +4,908,547 +4.2% 01 May 2024 10-Q 07 May 2024 2024 Q1
Q3 2023 118,499,945 +7,924,398 +7.2% 24 Oct 2023 10-Q 01 Nov 2023 2023 Q3
Q2 2023 117,737,289 +7,871,984 +7.2% 24 Jul 2023 10-Q 31 Jul 2023 2023 Q2
Q1 2023 116,457,008 +9,935,190 +9.3% 01 May 2023 10-Q 04 May 2023 2023 Q1
Q3 2022 110,575,547 +23,280,176 +27% 01 Nov 2022 10-Q 07 Nov 2022 2022 Q3
Q2 2022 109,865,305 +22,862,020 +26% 04 Aug 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 106,521,818 +26,025,047 +32% 29 Apr 2022 10-Q 04 May 2022 2022 Q1
Q3 2021 87,295,371 +11,558,447 +15% 02 Nov 2021 10-Q 08 Nov 2021 2021 Q3
Q2 2021 87,003,285 +11,399,294 +15% 03 Aug 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 80,496,771 +4,983,707 +6.6% 23 Apr 2021 10-Q 28 Apr 2021 2021 Q1
Q3 2020 75,736,924 +11,848,686 +19% 28 Oct 2020 10-Q 02 Nov 2020 2020 Q3
Q2 2020 75,603,991 +11,908,474 +19% 27 Jul 2020 10-Q 30 Jul 2020 2020 Q2
Q1 2020 75,513,064 +12,280,588 +19% 24 Apr 2020 10-Q 29 Apr 2020 2020 Q1
Q3 2019 63,888,238 +7,645,667 +14% 01 Nov 2019 10-Q 05 Nov 2019 2019 Q3
Q2 2019 63,695,517 +7,517,393 +13% 24 Jul 2019 10-Q 31 Jul 2019 2019 Q2
Q1 2019 63,232,476 +12,859,714 +26% 30 Apr 2019 10-Q 07 May 2019 2019 Q1
Q3 2018 56,242,571 05 Nov 2018 10-Q 13 Nov 2018 2018 Q3
Q2 2018 56,178,124 20 Jul 2018 10-Q 31 Jul 2018 2018 Q2
Q1 2018 50,372,762 12 Mar 2018 10-K 19 Mar 2018 2017 FY
Q4 2017 50,334,152 20 Dec 2017 10-Q 20 Dec 2017 2017 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.